profit from every $100 of sales.
$0$100
Viemed Healthcare
$9.13+1.67% today
+43.8% in 1 year
1-year low $6.261-year high $12.33
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $23.17 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Viemed Healthcare sold, what it kept, and what it did with the cash.
Sales went from $139 million in 2022 to $270 million in 2025, with $14.9 million of profit last year.
SalesProfit
Viemed Healthcare handed back more cash to shareholders than it generated last year.
Buybacks $15M
Free cash flow 2025$12M
Bought back its own shares$15M
Paid as dividends–
Cash vs. debt$14M vs. $16M
Viemed Healthcare vs. similar companies
Viemed Healthcare grows the fastest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Viemed Healthcare | 23.2× · Fair price | ||
 Boston Scientific | 22.6× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.8× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads Viemed Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 139 | 183 | 224 | 270 | |
| 85 | 113 | 133 | 155 | |
| 9 | 15 | 16 | 21 | |
| 25 | 37 | 42 | 52 | |
| 6 | 10 | 11 | 15 | |
| 0.16 | 0.25 | 0.28 | 0.37 | |
| 61.0% | 61.6% | 59.4% | 57.5% | |
| 6.2% | 8.2% | 7.1% | 7.7% | |
| 4.5% | 5.6% | 5.0% | 5.5% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 117 | 155 | 177 | 199 |
| Cash | 17 | 13 | 18 | 14 |
| Total debt | 1 | 10 | 7 | 16 |
| Total liabilities | 20 | 41 | 44 | 56 |
| 97 | 114 | 131 | 142 | |
| 40 | 40 | 41 | 41 | |
| 7.4% | 9.4% | 9.7% | 11.5% | |
| 6.4% | 9.0% | 8.6% | 10.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 28 | 45 | 39 | 52 | |
| 23 | 26 | 38 | 40 | |
| 5 | 19 | 1 | 12 | |
| Dividends paid | – | – | – | – |
| 10 | 1 | 1 | 15 | |
| 5 | 6 | 6 | 9 |
Valuation
- 23.2×
- 19.0×
- 0.72
- 2.6×
- 1.3×
- 29.0×
- 6.8×
- 3.4%
- 4.3%
- 0.0%
Profitability
- 57.5%
- 7.7%
- 5.5%
- 18.7%
- 10.5%
- 8.2%
- 10.7%
- 7.5%
- 15.3%
- 1.0%
Growth
- +24.9%
- +32.2%
- +805.2%
- –
- −0.4%
Financial health
- 0.1×
- 0.09
- 6.3%
- 18.4×
- 1.22
- 1.10
- 1.45
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 27%of 958
Bottom 44%of 888
Top 44%of 600
Top 22%of 889
Top 32%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | 0.06 | 0.09 | −33.3% |
| Mar 4, 2026 | 0.14 | 0.12 | +16.7% |
| Nov 5, 2025 | 0.09 | 0.09 | +0.0% |
| Aug 6, 2025 | 0.08 | 0.09 | −5.9% |
| May 7, 2025 | 0.06 | 0.06 | +0.0% |
| Mar 10, 2025 | 0.10 | 0.11 | −9.1% |
| Nov 6, 2024 | 0.10 | 0.08 | +25.0% |
| Aug 7, 2024 | 0.04 | 0.07 | −42.9% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
56No pass
Benjamin Graham
53No pass
Philip Fisher
72Pass
Peter Lynch
91Pass
Joel Greenblatt
34No pass
Charlie Munger
44No pass
Terry Smith
40No pass
Questions about Viemed Healthcare
Is Viemed Healthcare a good stock to buy?
A business with weak numbers at a fair price. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Viemed Healthcare AI analysis
What does Viemed Healthcare do?
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It is in Medical - Devices.
Does Viemed Healthcare pay a dividend?
No. Viemed Healthcare does not pay a dividend at the moment; in 2025 it returned $15.0 million to shareholders by buying back its own shares.
Is Viemed Healthcare stock halal?
Yes. Viemed Healthcare passes our halal screen: its business is permitted and its debt is 5% of its market value, under the 30% limit. How we check
How has Viemed Healthcare stock done over the past year?
Up 43.8% over the past twelve months, to $9.13. It traded between $6.26 and $12.33 and is 26.0% below its high.
Who are Viemed Healthcare's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Viemed Healthcare's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.